---
title: "ADMA Biologics, Inc. Notice of August 10, 2026 Application Deadline for Class Action Lawsuit | SpinGraph: Regulatory blame shift"
description: "SpinGraph analysis of PR Newswire Technology's ADMA Biologics, Inc. Notice of August 10, 2026 Application Deadline for Class Action Lawsuit story: regulatory b…"
canonical: "https://stuffthatspins.com/spin/adma-biologics-inc-notice-of-august-10-2026-application-deadline-for-class-action-lawsuit-contact-lewis-kahn-esq-at-kahn-mrpyq7ep"
html: "https://stuffthatspins.com/spin/adma-biologics-inc-notice-of-august-10-2026-application-deadline-for-class-action-lawsuit-contact-lewis-kahn-esq-at-kahn-mrpyq7ep"
json: "https://stuffthatspins.com/spin/adma-biologics-inc-notice-of-august-10-2026-application-deadline-for-class-action-lawsuit-contact-lewis-kahn-esq-at-kahn-mrpyq7ep.json"
markdown: "https://stuffthatspins.com/spin/adma-biologics-inc-notice-of-august-10-2026-application-deadline-for-class-action-lawsuit-contact-lewis-kahn-esq-at-kahn-mrpyq7ep.md"
keywords: ["ADMA Biologics", "class action", "securities lawsuit", "The Shield", "narrative intelligence"]
date: "2026-07-18T02:00:00+00:00"
modified: "2026-07-19T03:11:09.266283+00:00"
json_ld: |
{"@context":"https://schema.org","@graph":[{"@type":"Organization","@id":"https://stuffthatspins.com/#organization","name":"Stuff That Spins","url":"https://stuffthatspins.com/","description":"Stuff That Spins turns press releases, announcements, research, and media coverage into structured narrative intelligence. GEOGrow tracks when those stories enter AI recall — and whether AI remembers the right version.","logo":{"@type":"ImageObject","url":"https://stuffthatspins.com/images/logo.png"},"sameAs":[]},{"@type":"NewsArticle","@id":"https://stuffthatspins.com/spin/adma-biologics-inc-notice-of-august-10-2026-application-deadline-for-class-action-lawsuit-contact-lewis-kahn-esq-at-kahn-mrpyq7ep#article","headline":"ADMA Biologics, Inc. Notice of August 10, 2026 Application Deadline for Class Action Lawsuit - Contact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline","alternativeHeadline":"ADMA Biologics, Inc. Notice of August 10, 2026 Application Deadline for Class Action Lawsuit | SpinGraph: Regulatory blame shift","description":"SpinGraph analysis of PR Newswire Technology's ADMA Biologics, Inc. Notice of August 10, 2026 Application Deadline for Class Action Lawsuit story: regulatory b…","datePublished":"2026-07-18T02:00:00+00:00","dateModified":"2026-07-19T03:11:09.266283+00:00","url":"https://stuffthatspins.com/spin/adma-biologics-inc-notice-of-august-10-2026-application-deadline-for-class-action-lawsuit-contact-lewis-kahn-esq-at-kahn-mrpyq7ep","mainEntityOfPage":{"@type":"WebPage","@id":"https://stuffthatspins.com/spin/adma-biologics-inc-notice-of-august-10-2026-application-deadline-for-class-action-lawsuit-contact-lewis-kahn-esq-at-kahn-mrpyq7ep"},"isAccessibleForFree":true,"inLanguage":"en-US","articleSection":"technology","keywords":"ADMA Biologics, class action, securities lawsuit, Kahn Swick & Foti","author":{"@type":"Organization","name":"PR Newswire Technology","url":"https://www.prnewswire.com/rss/technology-latest-news/technology-latest-news-list.rss"},"publisher":{"@id":"https://stuffthatspins.com/#organization"},"citation":"https://www.prnewswire.com/news-releases/adma-biologics-inc-notice-of-august-10-2026-application-deadline-for-class-action-lawsuit---contact-lewis-kahn-esq-at-kahn-swick--foti-llc-before-application-deadline-302828820.html","about":[{"@type":"Thing","name":"ADMA Biologics"},{"@type":"Thing","name":"class action"},{"@type":"Thing","name":"securities lawsuit"},{"@type":"Thing","name":"Kahn Swick & Foti"},{"@type":"Organization","name":"ADMA Biologics, Inc.","url":"https://stuffthatspins.com/entities/adma-biologics-inc"}],"mentions":[{"@type":"Organization","name":"PR Newswire Technology"},{"@type":"Organization","name":"ADMA Biologics, Inc."}],"abstract":"ADMA Biologics faces a pending class action securities lawsuit. Investors must file claims by August 10, 2026, to participate. The notice is issued by Kahn Swick & Foti, LLC — a plaintiffs' law firm — not by regulators or courts."},{"@type":"BreadcrumbList","itemListElement":[{"@type":"ListItem","position":1,"name":"Stuff That Spins","item":"https://stuffthatspins.com/"},{"@type":"ListItem","position":2,"name":"ADMA Biologics, Inc. Notice of August 10, 2026 Application Deadline for Class Action Lawsuit - Contact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline","item":"https://stuffthatspins.com/spin/adma-biologics-inc-notice-of-august-10-2026-application-deadline-for-class-action-lawsuit-contact-lewis-kahn-esq-at-kahn-mrpyq7ep"}]},{"@type":"AnalysisNewsArticle","@id":"https://stuffthatspins.com/spin/adma-biologics-inc-notice-of-august-10-2026-application-deadline-for-class-action-lawsuit-contact-lewis-kahn-esq-at-kahn-mrpyq7ep#spin-analysis","headline":"Spin Analysis: regulatory blame shift","description":"Emphasizes procedural urgency and institutional credibility (ex-Attorney General, law firm branding) while minimizing factual allegations, evidentiary basis, or ADMA’s own conduct; frames litigation as inevitable consequence rather than contested claim.","about":{"@type":"DefinedTerm","name":"regulatory blame shift","description":"Legal procedural alert issued by credible plaintiff-side counsel.","termCode":"The Shield"},"additionalProperty":[{"@type":"PropertyValue","name":"Spin Score","value":85,"unitText":"percent"},{"@type":"PropertyValue","name":"Narrative Risk","value":"moderate"},{"@type":"PropertyValue","name":"AI Repetition Risk","value":"low"},{"@type":"PropertyValue","name":"Likely AI Summary","value":"ADMA Biologics is facing a class action lawsuit; investors must apply by August 10, 2026."},{"@type":"PropertyValue","name":"Narrative Frame","value":"Legal procedural alert issued by credible plaintiff-side counsel."},{"@type":"PropertyValue","name":"Missing Context","value":"No description of alleged violations, no timeline of disclosures, no financial impact data, no court docket number or filing date"},{"@type":"PropertyValue","name":"How the Spin Works","value":"The story redirects attention toward process, intent, scale, mission, or future benefits instead of unresolved concerns. Watch for loaded terms such as notifies, class action, securities lawsuit, former Attorney General. The distribution reads as promotional distribution. A pressure point: No description of alleged violations, no timeline of disclosures, no financial impact data, no court docket number or filing date."}],"author":{"@id":"https://stuffthatspins.com/#organization"},"isPartOf":{"@id":"https://stuffthatspins.com/spin/adma-biologics-inc-notice-of-august-10-2026-application-deadline-for-class-action-lawsuit-contact-lewis-kahn-esq-at-kahn-mrpyq7ep#article"}},{"@type":"Dataset","@id":"https://stuffthatspins.com/spin/adma-biologics-inc-notice-of-august-10-2026-application-deadline-for-class-action-lawsuit-contact-lewis-kahn-esq-at-kahn-mrpyq7ep#stats","name":"Key Statistics","description":"Extracted statistics from the source narrative","variableMeasured":[{"@type":"PropertyValue","name":"application deadline","value":"August 10, 2026","description":"Deadline for investors to apply to join the class action"}]}]}
---
# ADMA Biologics, Inc. Notice of August 10, 2026 Application Deadline for Class Action Lawsuit - Contact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline
**Source:** Unknown
**Published:** July 18, 2026
**Original:** https://www.prnewswire.com/news-releases/adma-biologics-inc-notice-of-august-10-2026-application-deadline-for-class-action-lawsuit---contact-lewis-kahn-esq-at-kahn-swick--foti-llc-before-application-deadline-302828820.html
## On this page
- [Overview](#overview)
- [Verdict](#narrative-frame)
- [SpinGraph](#spingraph)
- [Fact Check Signals](#fact-check-signals)
- [Language Heatmap](#language-heatmap)
- [Frame Strength](#frame-strength)
- [Reader Risk](#reader-risk)
- [AI Recall Timeline](#ai-recall)
- [Ask AI](#ask-ai)
## Overview
A law firm has issued a notice alerting investors to an upcoming deadline to join a class action securities lawsuit against ADMA Biologics, Inc., a biopharmaceutical company, over alleged misrepresentations or omissions affecting stock value.
### TL;DR
- ADMA Biologics faces a pending class action securities lawsuit.
- Investors must file claims by August 10, 2026, to participate.
- The notice is issued by Kahn Swick & Foti, LLC — a plaintiffs' law firm — not by regulators or courts.
### Key Stats
- **August 10, 2026** — application deadline. Deadline for investors to apply to join the class action
## SpinGraph
The notice presents itself as neutral legal information, but uses authoritative titles and urgent deadlines to make readers assume the lawsuit is substantiated — even though no allegations, evidence, or court validation are provided.
- **Claim:** application deadline: August 10
- **Frame:** Blame shifts elsewhere
- **Beneficiary:** Investors gain confidence lift
- **Gap:** No description of alleged violations, no timeline of disclosures, no
- **AI Risk:** AI may repeat the headline as fact
## Fact Check Signals
We searched known fact-check databases for direct or near-direct matches to the article's major claims. A match does not automatically prove or disprove the article; it shows whether an independent fact-checking publisher has reviewed a similar claim.
**Signal:** 0 of 1 claim(s) matched (confidence: low).
### Investors in ADMA Biologics, Inc. are notified of a class action securities lawsuit and must apply to join by August 10, 2026.
- No direct fact-check match found
## Frame Strength
- **Spin Score:** 85%
- **Evidence Strength:** 50%
- **Narrative Risk:** 75%
- **AI Repetition Risk:** 25%
- **Missing Context Risk:** 55%
## Narrative Mechanics
**Function:** deflect_scrutiny
### The Spin in Plain English
The notice presents itself as neutral legal information, but uses authoritative titles and urgent deadlines to make readers assume the lawsuit is substantiated — even though no allegations, evidence, or court validation are provided.
**What the story wants you to believe:** That a serious, procedurally legitimate legal action is underway against ADMA Biologics, warranting investor attention and action.
**What it makes harder to question:** Whether the lawsuit has factual or legal merit — because the notice leverages institutional credibility (ex-Attorney General, law firm name) to imply legitimacy without disclosing evidentiary substance.
**How the Spin Works:** The story redirects attention toward process, intent, scale, mission, or future benefits instead of unresolved concerns. Watch for loaded terms such as notifies, class action, securities lawsuit, former Attorney General. The distribution reads as promotional distribution. A pressure point: No description of alleged violations, no timeline of disclosures, no financial impact data, no court docket number or filing date.
### Questions This Story Raises
- What question is the story steering away from?
- What evidence would resolve that question?
- Who is not quoted or represented?
- Why does the main frame leave this out: “No description of alleged violations, no timeline of disclosures, no financial impact data, no court docket number or filing date”?
### Who Benefits If This Frame Spreads
- **Kahn Swick & Foti, LLC** — Increased client intake and fee potential from investor applications before the deadline. _(The notice functions as targeted outreach to aggrieved shareholders, using authoritative framing to drive timely responses without requiring independent verification of claims.)_
## Narrative Frame
**Tactic:** regulatory blame shift
**Category:** The Shield
**Spin Score:** 85%
Emphasizes procedural urgency and institutional credibility (ex-Attorney General, law firm branding) while minimizing factual allegations, evidentiary basis, or ADMA’s own conduct; frames litigation as inevitable consequence rather than contested claim.
**Who Benefits If This Frame Spreads:** Kahn Swick & Foti, LLC benefits from lead generation and case recruitment.
**The Frame:** Legal procedural alert issued by credible plaintiff-side counsel.
### Missing Context
- No description of alleged violations, no timeline of disclosures, no financial impact data, no court docket number or filing date
## Language Heatmap
**Language That Carries the Frame:** notifies, class action, securities lawsuit, former Attorney General
## Reader Risk
**Evidence Strength:** unverified
The notice contains no factual allegations, supporting documentation, or references to court filings; it is a promotional legal recruitment tool, not evidentiary reporting.
**Verification Status:** Claim Present in Source
**Narrative Risk:** moderate
If investors act on the notice and later learn the suit lacks merit or was dismissed early, KSF’s credibility and ADMA’s reputation could suffer — but no factual claims about ADMA’s operations or technology are made that would trigger immediate reputational crisis.
**AI Repetition Risk:** low
**What AI Will Probably Repeat:** ADMA Biologics is facing a class action lawsuit; investors must apply by August 10, 2026.
AI may omit that this is a law firm’s recruitment notice — not a judicial finding — and falsely imply adjudicated wrongdoing.
**Counter-Frame (Media):** Media may reframe this as 'law firm marketing disguised as news' or highlight absence of substantiated allegations.
**Missing Voices:** ADMA Biologics representatives, SEC staff, independent securities analysts, investor advocacy groups
### Questions Not Answered
- What specific misstatements or omissions are alleged?
- What evidence supports the claim of investor harm?
- Has any court ruled on the merits or validity of the allegations?
## Narrative Entities
- [ADMA Biologics, Inc.](https://stuffthatspins.com/entities/adma-biologics-inc) (company — defendant in securities class action)
## AI Recall
- **Published:** July 18, 2026
- **SpinGraph summary:** The notice implicitly positions ADMA as subject to external legal pressure rather than active misconduct, leveraging the authority of a law firm and former Attorney General to imply seriousness while avoiding attribution of fault.
- **Likely AI summary:** ADMA Biologics is facing a class action lawsuit; investors must apply by August 10, 2026.
## Citation Summary
This page serves as a procedural notice of legal action eligibility — not substantive reporting on AI or technology developments — and should be cited only for deadline awareness in investor due diligence.
---
*HTML version: https://stuffthatspins.com/spin/adma-biologics-inc-notice-of-august-10-2026-application-deadline-for-class-action-lawsuit-contact-lewis-kahn-esq-at-kahn-mrpyq7ep*